by Pharma blister packaging involves packaging pharmaceutical products in cavities or pockets made from plastic, paper, and aluminum foils. Blister packs provide product protection, tamper evidence, and ease of use. They are used for packaging tablets, capsules, injections, and ointments. Blister packs offer product visibility and stability, preventing breakage and achieving longer shelf life. Their use has been rising in packaging pharmaceutical products that have a short shelf life or are moisture-sensitive. Blister packs effectively prevent damage, contamination, and product expiration. They allow quick identification ofmedicine and dosages through the clear packaging material.
The global pharma blister packaging market is estimated to be valued at US$ 9.5 billion in 2023 and is expected to exhibit a CAGR of 5.0% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Dynamics:
One of the key drivers augmenting the pharma blister packaging market growth is the growing demand for efficient drug delivery solutions. Blister packs protect pharmaceuticals and enable easier identification and consumption compared to other packaging types such as bottles and pouches. They provide tamper evidence and allow viewing of products without opening. This drives their use in packaging tablets, capsules, and other oral medication. Furthermore, blister packs extend shelf life through preserving product quality and preventing contamination till consumption. Their advantages in drug delivery have been fueling their rising uptake in the pharmaceuticals industry. Additionally, the need for senior-friendly and patient-centric packaging is propelling the transition toward blister packs from other packaging types. By making tablets removal convenient, blister packs facilitate independent medicine intake for the elderly population. This growing demand for senior-friendly packaging solutions is expected to boost the pharma blister packaging market expansion during the forecast period.
Segment Analysis
The pharma blister packaging market is dominated by the thermoform blister packaging segment. Around 80% of pharmaceutical products opt for thermoform blister packaging as the preferred packaging format owing to its benefits like ease of packaging, protection from moisture, and tamper evidence. Thermoform blister packaging provides high quality packaging and longer shelf-life to medicines.
PEST Analysis
- Political: The pharma packaging industry is highly regulated by various agencies to ensure compliance with stringent packaging norms and patient safety standards. New regulations promote sustainable and eco-friendly packaging formats.
- Economic: The global economy is recovering post-pandemic which is fueling healthcare spends and boosting the demand for pharmaceutical products. Higher income levels in developing regions also augment the market growth.
- Social: Aging population worldwide drives the demand for pharmaceuticals and impacts the packaging needs. Lifestyle diseases and customized medicine packets as per patient needs influence the packaging trends.
- Technological: Digital printing, auto-inspection, and robotics are improving the production efficiencies. Smart blister packs with IoT enablement and authentication features are gaining traction. New materials like bio-plastics provide opportunities.
Key Takeaways
The global pharma blister packaging market is expected to witness high growth over the forecast period of 2023 to 2030. The global pharma blister packaging market is estimated to be valued at US$ 9.5 billion in 2023 and is expected to exhibit a CAGR of 5.0% over the forecast period 2023 to 2030.
Regional analysis comprises: The North American region dominates the global pharma blister packaging market. This is attributed to the well-established pharmaceutical industry and strict packaging regulations in the US and Canada. Europe is another major regional market driven by generics packaging demand. The Asia Pacific region is projected to demonstrate the fastest growth led by China, India and other developing countries.
Key players operating in the Pharma Blister Packaging market are ACG, Amcor, Bemis, Constantia Flexibles, and Honeywell International. Key players like ACG and Amcor dominate the thermoform blister packaging segment globally.
